SCA2 and SCA3 mutations in young-onset dopa-responsive parkinsonism

M. Svetel, A. Djarmati, N. Dragašević, D. Savić, B. Čuljković, S. Romac, V. S. Kostić*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

In this study no one of our 85 patients of Serbian origin with young-onset (≤ 45 years) dopa-responsive parkinsonism (YOP), previously proved negative for PARK1 and PARK2 mutations, had either spinocerebellar ataxia type 2 (SCA2) or SCA3 mutation. These data do not prove the significance of these two mutations in either sporadic or familial YOP suggestive of Parkinson's disease.

Original languageEnglish (US)
Pages (from-to)597
Number of pages1
JournalEuropean Journal of Neurology
Volume10
Issue number5
DOIs
StatePublished - Sep 2003
Externally publishedYes

Keywords

  • SCA2
  • SCA3
  • Young-onset parkinsonism

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Fingerprint

Dive into the research topics of 'SCA2 and SCA3 mutations in young-onset dopa-responsive parkinsonism'. Together they form a unique fingerprint.

Cite this